Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Thursday 15 & Friday 16 January 2015

The Department of Physiology, Anatomy & Genetics at the University of Oxford in conjunction with the Nuffield Department of Surgical Sciences is running a pioneering new course to practice a new technique of removing cancer in the bowel.

The procedure is being performed using the latest camera technology so that instead of having to open up the patient's abdomen (which is very invasive), the operation can be done minimally invasively. This is a brand new technique and Oxford is leading the way in teaching surgeons across Europe how to do the procedure.

Interested journalists are welcome to come down, film / photgraph and meet the course organisers - they could also try the cameras which viewers might find interesting.... this has the potential to revolutionise the way we treat colon cancer.

 

Visits will ONLY be possible on Friday morning.

Journalists who are interetsed and require more information, please contact Frances Valentine, course co-ordinator, on 07726 312 719.

 

Similar stories

PRINCIPLE Covid-19 treatments trial widens to under 50s and adds colchicine

Clinical Trials Coronavirus COVID-19 General Research

From today, the UK’s national priority platform trial of Covid-19 treatments for recovery at home launches its investigation of the gout drug colchicine, and expands for the first time to include adults of any age.

Regular meat consumption linked with a wide range of common diseases

Research

Regular meat consumption is associated with a range of diseases that researchers had not previously considered, according to a large, population-level study conducted by a team at the University of Oxford.

New data show vaccines reduce severe COVID-19 in older adults

Coronavirus COVID-19 Research

New data show both Oxford / AstraZeneca vaccine and the Pfizer-BioNTech vaccines significantly reduce severe COVID-19 in older adults.

Singula Bio, a new Oxford spin-out company - Cancer need not be fatal

General Innovation Research

Singula Bio, a bold new seed-stage biotechnology company spun out of Oxford University, has been launched with the intention of helping show that cancer need not be fatal. Led by three Oxford cancer specialists, the firm is aims to become a world leader in therapies to use against difficult-to-treat solid malignancies such as ovarian cancer - using the body’s own immune system to fight previously fatal cancers.

Major rise in public support for COVID vaccine – Oxford study

Coronavirus COVID-19 General Research

More than three quarters of people in the UK now say they are ’very likely’ to have the vaccine – up from 50% among the same group of survey respondents five months ago –according to a two-wave Oxford University survey published today.